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Since 2011 Romania is experiencing a dramatic increase of
newly diagnosed HIV infections among injecting drug
users (IDUs), mainly linked to the introduction of new
psychoactive substances (NPS) on the Romanian market,
their use being related to higher levels of risk behavior
compared to opioid abuse. There is no sufficient data
showing the natural course of HIV in subjects infected
through IDU – the majority are ART-naïve due to recently
acquired infection (many are asymptomatic and have a
CD4 cell count over 350 cells/cmm) and poor adherence.
Our objective was to determine if IDUs have a faster
decline in CD4 cells than sexually-infected patients.
We performed a retrospective study, including ART-
naïve HIV-positive patients diagnosed between January
2011 and June 2013 at the National Institute for Infectious
Diseases “Prof. Dr. Matei Balş”, who had 2 subsequent
CD4 cell count determinations over a timespan of 6-24
months and a baseline CD4 count higher than 350 cells/
cmm. Among 1,248 newly diagnosed patients, 234 met
these inclusion criteria. The data were statistically analyzed
using SPSS version 17 (independent sample t-test, Mann-
Whitney test, linear regression; the significance level was
set at 0.05).
The majority (80%, 187/234) were men and the med-
ian age was 29 years (15-76). More than half of the
patients (138; 59%) were former or active IDUs, with
low socioeconomic status, most of them injecting both
opioids and NPS and 55 (40%) of them were in deten-
tion at the moment of HIV diagnosis. Among them,
98% were coinfected with HCV, as opposed to only 21%
of the sexually-infected patients. Subtype analysis was
performed for 64 patients and revealed the following
subtypes and circulating recombinant forms (CRF): 50
F1, 3 B, 10 CRF14_BG and 1 CRF14_F. There was no
significant difference of CD4 cell count between the two
groups at baseline (p=0.55). The median variation of
CD4 cells in IDUs was 150 and 42 in the non IDUs
group. IDUs had a statistically significant CD4 cell
decline (p=0.01). HCV coinfection was also correlated
with a faster decline in CD4 cells (p <0.001).
The more rapid decline of CD4 cells among IDUs
could be explained by direct effect of drugs, differences
in the virulence of the HIV strains circulating among
IDUs and HCV coinfection. These data highlight the
importance of carefully monitoring IDUs with HIV
infection and of initiating ART earlier in this risk group.
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